Abecab 5 mg+20 mg (Tablet)
Unit Price: ৳ 12.00 (5 x 10: ৳ 600.00)
Strip Price: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Amlodipine besilate olmesartan medoxomil |
Company | Aci limited |
Also available as |
Indications and Usage
- Treatment of hypertension alone or with other antihypertensive agents
- Lowering blood pressure
- Initial therapy in patients likely to need multiple antihypertensive agents
- Individualized therapy based on baseline blood pressure and target goal
Pharmacology
- Amlodipine as a dihydropyridine calcium channel blocker
- Amlodipine's effect on vascular smooth muscle cells and cardiac muscle cells
- Olmesartan Medoxomil as an angiotensin II receptor blocker
- Blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II
Dosage and Administration
- Substitute individually titrated components
- Initial therapy at 5/20 mg once daily
- Titration up to a maximum of 10/40 mg once daily
- Adjusted starting dose for elderly patients
Interactions
- Attenuation of antihypertensive effect by NSAIDs including selective COX-2 inhibitors
- Closely monitoring blood pressure, renal function, and electrolytes
Contraindications
- Co-administration with Aliskiren in patients with diabetes
Side Effects
- Common side effects include peripheral edema, headache, flushing, and dizziness
- Possibility of causing sprue-like enteropathy
Pregnancy and Lactation
- Pregnancy Category D
- Not for use in 2nd and 3rd trimester due to potential fetal death
- Consideration for discontinuing drug during nursing
Precautions and Warnings
- Caution for hypotension in volume- or salt-depleted patients
- Risk of vasodilation in patients with severe aortic stenosis
- Potential for increased angina or acute MI in patients with severe obstructive coronary artery disease
Use in Special Populations
- Unestablished safety and effectiveness in pediatric patients
- No overall differences in safety or effectiveness observed in subjects 65 years of age or older
- No studies in patients with renal impairment
- Initial therapy not recommended in hepatically impaired patients
Overdose Effects
- No information available on human overdosage
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C
- Keep away from light
- Keep out of the reach of children